Parenteral Nutrition-related Hepatitis Clinical Trial
Official title:
Use of Omegaven for Treatment With Parenteral Nutrition Associated Liver Disease
To provide parenteral fat emulsion prepared from fish oil (omega-3 fatty acid emulsion, Omegaven®) to patients with liver disease (PNALD).
This is a compassionate use protocol for patients with PNALD who have failed traditional treatment to receive Omegaven through an IND. Omegaven will be infused intravenously through either a central or peripheral catheter in conjunction with parenteral nutrition. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04347902 -
Lipid Emulsions and Liver Function - Results After 5 Years.
|
Phase 4 |